Abiopharma

Accelerant Announces Second Quarter 2026 Results

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

McGraw Hill, Inc. Reports Strong Fiscal First Quarter 2027 Results Exceeding Expectations

New Form SCHEDULE 13G/A - Silo Pharma, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088836 <b>Size:</b> 12 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023648 <b>Size:</b> 1 MB

New Form 424B2 - NOMURA HOLDINGS INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001104659-26-095587 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - Sunshine Biopharma Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088834 <b>Size:</b> 11 KB

Mandatory Cash Dividend/ Distribution:

Financial Statements and Related Announcement: Half Yearly Results

Venu Holding Corporation Reports Second Quarter Fiscal 2026 Financial Results

New Form SCHEDULE 13G/A - eHealth, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000185 <b>Size:</b> 8 KB

New Form SCHEDULE 13G/A - Longeveron Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088831 <b>Size:</b> 11 KB

New Form FWP - BANK OF MONTREAL /CAN/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001214659-26-010033 <b>Size:</b> 140 KB

New Form SCHEDULE 13G/A - GeoVax Labs, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088830 <b>Size:</b> 14 KB